Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

Medical Daily

Colorectal Cancer Is Now the Top Cancer Killer of Americans Under 50: What an Oncologist Wants Younger Adults to Know

Cancer ACS American Cancer Society Bacteria Nature

^{Editorial Note: This article is an internal production sample used exclusively for contributor outreach. All content, author bios, and associated data are strictly illustrative and fictional.}

For decades, colorectal cancer was considered a disease of older adults. That picture has changed. Colorectal cancer is now the leading cause of cancer death in Americans younger than 50 and the second leading cause of cancer death overall, according to the American Cancer Society's Colorectal Cancer Statistics, 2026 report.

Oncologists increasingly treat patients in their 30s and 40s who never imagined this diagnosis was possible for them. Many had symptoms for months that they, or their doctors, attributed to something minor. That delay is one of the few parts of this trend we can actually change.

What the New Numbers Show

The ACS estimates that 158,850 Americans will be diagnosed with colorectal cancer in 2026 and 55,230 will die from it.

The overall numbers hide two very different stories. From 2013 to 2022, incidence fell 2.5% per year in adults 65 and older, but rose 3% per year in adults aged 20 to 49 and 0.4% per year in those aged 50 to 64. The increase is concentrated in the lower colon and rectum. Rectal cancer now makes up 32% of all colorectal cancers, up from 27% in the mid-2000s.

Deaths are following the same pattern. Mortality in adults younger than 50 has increased by 1% per year since 2004, while it has fallen 2.3% per year in adults 65 and older since 2012. In adults aged 50 to 64, the rise in cases was confined to cancers that had already spread regionally or distantly.

That last detail matters. It suggests many younger patients are being diagnosed later, when the disease is harder to treat.

Why Is This Happening?

The honest answer is that no one knows for certain. Established risk factors for colorectal cancer include obesity, physical inactivity, diets high in red and processed meat, alcohol and smoking. These may contribute, but most researchers do not believe they fully explain a rise this steep and this widespread. Many young patients I see do not fit any typical risk profile.

One of the most intriguing leads came from a 2025 study in Nature. Researchers led by the University of California San Diego sequenced 981 colorectal cancer genomes from patients in 11 countries. They found that DNA damage patterns linked to colibactin, a toxin produced by certain strains of E. coli bacteria in the gut, were 3.3 times more common in patients diagnosed before age 40 than in those diagnosed after 70. The mutations appeared early in tumor development, and the authors suggested that exposure to colibactin-producing bacteria in early life may contribute to rising early-onset cases.

This is important research, but readers should understand its limits. It shows an association, not proof that colibactin causes most early-onset cancers. Scientists still need to determine how children become exposed to the toxin or the bacteria that produce it, and the findings need confirmation. There is currently no test or treatment based on this discovery that patients can use.

The Symptoms Younger Adults Should Not Ignore

Because most people under 45 are not being screened, symptoms are often the first sign. The ACS lists rectal bleeding, abdominal pain, diarrhea and iron-deficiency anemia as red-flag symptoms that deserve attention.

Most of the time, these symptoms have a harmless cause such as hemorrhoids or a temporary stomach bug. The problem arises when they persist and are repeatedly explained away because a patient "seems too young" for cancer. Blood in the stool that doesn't go away, or anemia without a clear explanation, should prompt a conversation about further evaluation, which sometimes means a colonoscopy.

Screening Starts at 45

For adults at average risk, the ACS recommends beginning screening at age 45. ACS researchers have specifically called for increasing screening in people aged 45 to 54 and for educating both clinicians and the public about symptoms.

People with a higher risk, such as a family history of colorectal cancer, may be advised to start earlier. Screening options include colonoscopy and at-home stool-based tests. If a stool test comes back positive, the follow-up colonoscopy is not optional. It is part of the screening process, and skipping it undoes much of the benefit.

Screening works in two ways. It can find cancer early, and during a colonoscopy, doctors can remove precancerous growths called polyps before they ever become cancer.

What Oncologists Want Patients To Know

A young-onset diagnosis brings concerns older patients may not face. Treatment for rectal cancer in particular can affect fertility, sexual function and bowel control. The ACS report calls for provider conversations about treatment side effects and the preservation of reproductive and sexual health for younger patients. Anyone newly diagnosed should ask about fertility preservation before treatment begins, because some options are only available beforehand.

It's also worth knowing that colorectal cancer is highly treatable when caught early. The rising numbers are alarming, but they are not a reason for panic. They are a reason to take symptoms seriously and to get screened on time.

What Remains Uncertain

Several major questions remain open. Researchers do not know why the increase is concentrated in the rectum and lower colon, whether early-life gut bacteria are a major driver, or whether screening before 45 would be worthwhile for the general population. Because cancer registry data lag behind the calendar year, the most recent incidence figures in the ACS report run only through 2022.

The Bottom Line

Colorectal cancer is becoming more common and more deadly in adults under 65, and science has not yet explained why. What is clear is that persistent symptoms deserve a real evaluation regardless of age, and that screening beginning at 45 remains one of the most effective tools we have against this disease.

About the Author

Alex Example, MD

Alex Example, MD, is a board-certified medical oncologist at Placeholder University Cancer Institute in Sampleville, ST, where he specializes in colorectal and other gastrointestinal cancers, with a focus on patients diagnosed before age 50. He completed his hematology and oncology fellowship at Example University Medical Center and directs the institute's Young-Onset Colorectal Cancer Clinic. His work focuses on survivorship, fertility preservation, and earlier diagnosis in younger adults.

Contact: Gastrointestinal Oncology Program, Placeholder University Cancer Institute, 200 Demo Avenue, Sampleville, ST 00002 | [email protected] | (555) 010-0202

Disclosures: Dr. Example reports no relevant financial relationships.